AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
$25.47 0.33 (1.3126%)
Analysed AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) News Sources
Amphastar (AMPH) Q2 2026 Earnings Call Transcript
14-08-2026
fool.com
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call
15-08-2026
yahoo.com
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
01-09-2026
yahoo.com
Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting
05-09-2026
yahoo.com
Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued?
06-09-2026
yahoo.com
Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group
17-09-2026
yahoo.com
3 Reasons to Avoid AMPH and 1 Stock to Buy Instead
24-09-2026
yahoo.com
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
06-10-2026
yahoo.com
1 Safe-and-Steady Stock to Research Further and 2 Facing Challenges
08-10-2026
yahoo.com
Amphastar Pharmaceuticals (AMPH) Stock Looks About Right After A 42% Slide
17-10-2026
yahoo.com
What is the current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is $25.47.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is $0.33.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is 1.3126%.
What is the most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is .
SEC-8K** Filing Available For AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.